Skip to main contentSkip to navigation
Sirius Investors
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

TEVJF
OTCHealthcare

Revenue Analysis - TEVJF

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

TEVJF Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$3.4B

Distribution Service

0.0% of total revenue

$396.0M

Product and Service, Other

0.0% of total revenue

$157.0M

License

0.0% of total revenue

$39.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Distribution Service
License
Product
Product and Service, Other
3/31/2026$396.0M$39.0M$3.4B$157.0M
6/30/2025$377.0M$46.0M$3.6B$117.0M
3/31/2025$384.0M$36.0M$3.4B$76.0M
12/31/2024$1.2B$128.0M$10.6B$263.0M
9/30/2024$390.0M$45.0M$3.8B$102.0M
6/30/2024$382.0M$36.0M$3.6B$106.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Product and Service, Other+34.2%
Declining Segments
License-15.2%

Geographic Regions

Growing Regions
Other Activities+151.7%
Declining Regions
United States Segment-28.7%

Earnings Reports

Want to see how TEVJF's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports